The serum concentrations of type I IFN, IL-6, and TNF-α were significantly reduced when patients were induced to remission by methotrexate and tocilizumab, suggesting that the production of type I IFN, IL-6, and TNF-α induced by the novel coronavirus vaccine may be associated with cases of newly onset RA. Here, IL6 is linked to rheumatoid arthritis.